SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-014495
Filing Date
2017-08-11
Accepted
2017-08-11 14:25:41
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tlcc20170630_10q.htm 10-Q 713440
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16326
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16345
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7376
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7501
  Complete submission text file 0001437749-17-014495.txt   4935698

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS tlcc-20170630.xml EX-101.INS 1049319
7 EXHIBIT 101.SCH tlcc-20170630.xsd EX-101.SCH 54576
8 EXHIBIT 101.CAL tlcc-20170630_cal.xml EX-101.CAL 39931
9 EXHIBIT 101.DEF tlcc-20170630_def.xml EX-101.DEF 354705
10 EXHIBIT 101.LAB tlcc-20170630_lab.xml EX-101.LAB 299398
11 EXHIBIT 101.PRE tlcc-20170630_pre.xml EX-101.PRE 373760
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55181 | Film No.: 171024354
SIC: 2833 Medicinal Chemicals & Botanical Products